NPI: 1336319607 · REDLANDS, CA 92374 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 03/03/2008
Authorized official WINSTEL, JOHN controls 20+ related entities in our dataset. Read more
| Authorized Official | WINSTEL, JOHN (CHIEF ACCOUNTING OFFICER) |
| NPI Enumeration Date | 03/03/2008 |
Other providers sharing the same authorized official: WINSTEL, JOHN
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 8,858 | $481K |
| 2019 | 10,106 | $510K |
| 2020 | 11,524 | $453K |
| 2021 | 15,545 | $570K |
| 2022 | 15,042 | $570K |
| 2023 | 17,541 | $732K |
| 2024 | 11,678 | $954K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 30,510 | 2,689 | $4.20M |
| A4657 | Syringe, with or without needle, each | 2,301 | 1,300 | $51K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 24,922 | 1,833 | $18K |
| J1756 | Injection, iron sucrose, 1 mg | 7,387 | 1,870 | $2K |
| 85041 | 1,181 | 1,136 | $525.20 | |
| 90674 | 54 | 53 | $29.94 | |
| 85048 | 1,180 | 1,135 | $0.00 | |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 616 | 350 | $0.00 |
| 85045 | 395 | 364 | $0.00 | |
| 83970 | 756 | 673 | $0.00 | |
| 83540 | 420 | 403 | $0.00 | |
| 90662 | 13 | 13 | $0.00 | |
| 82728 | 420 | 403 | $0.00 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 191 | 137 | $0.00 |
| J1270 | Injection, doxercalciferol, 1 mcg | 13,690 | 985 | $0.00 |
| 0250 | 5,867 | 358 | $0.00 | |
| 83550 | 307 | 297 | $0.00 | |
| G0008 | Administration of influenza virus vaccine | 40 | 40 | $0.00 |
| 82607 | 19 | 19 | $0.00 | |
| 82746 | 25 | 25 | $0.00 |